Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.40 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CTSS | P25774 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3074441 | 1.00 | CTSB (0.44) | CTSBADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL3074436 | 1.00 | CTSB (0.44) | CTSBADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL9960824 | 1.00 | CTSB (0.44) | CTSBADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL11888722 | 0.94 | CTSB (0.41) | CTSBADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL7902222 | 0.94 | CTSB (0.41) | CTSBADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL2798114 | 0.93 | CTSB (0.40) | CTSBADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL2798118 | 0.93 | CTSB (0.40) | CTSBADRB3ADRA2BADRA2CCYP3A4 | |
| Paritaprevir SCHEMBL3069969 | 0.92 | CTSB (0.45) | CTSBADRB3ADRA2BADRA2CCYP3A4 | |
| Paritaprevir SCHEMBL16541443 | 0.92 | CTSB (0.45) | CTSBADRB3ADRA2BADRA2CCYP3A4 | |
| Paritaprevir SCHEMBL18923192 | 0.92 | CTSB (0.45) | CTSBADRB3ADRA2BADRA2CCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2340029-B1 | MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS | ENANTA PHARM INC (US) | 2014-03-05 | — | — | EP | claimed |